A value‐based healthcare model for initiating and switching psoriasis therapies—Results from the prospective multicentre <scp>IMPROVE</scp> study

The model evaluated herein is the first value-based model to calculate remuneration from patient reported outcomes and showed to successfully predict the expected PBI and remunerate treatment based on whether the expected treatment goal was met or exceeded. This can be utilized in the patient-centred management of PsO.